Background and purpose The scientific literature on COVID‐19 is increasingly growing.
Methods In this paper, we review the literature on movement disorders in the context of the …

As neurological complications associated with COVID‐19 keep unfolding, the number of
cases with COVID‐19‐associated de novo movement disorders is rising. Although no clear …

Background Neurological symptoms are common manifestation in acute COVID-19. This
includes hyper-and hypokinetic movement disorders. Data on their outcome, however, is …

Background Neurological manifestations of severe acute respiratory syndrome coronavirus
2 (SARS‐CoV‐2) are being widely documented. However, movement disorders in the …

It is not established whether SARS-CoV-2 (COVID-19) patients with movement disorders,
are at greater risk for more serious outcomes than the larger COVID-19 population beyond …

Methods: We reviewed the scientific literature published in English, spanning from the initial
descriptions of COVID-19 until January 25, 2021, in the PubMed/MEDLINE database …

Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic in
December 2019, neurological manifestations have been recognized as potential …

Background There remains a scarcity of literature regarding COVID-19 and its neurological
sequelae. This study highlights Parkinsonism as a post-COVID-19 sequela and helps us …

Human coronaviruses have classically caused mild respiratory infections. Two previous
outbreaks caused by newly identified coronaviruses, SARS-CoV in 2002 and MERS-CoV in …

Movement disorders as a new neurological clinical picture in severe SARS‐CoV‐2 infection
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …